Timo Sarajärvi

949 total citations
21 papers, 680 citations indexed

About

Timo Sarajärvi is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Timo Sarajärvi has authored 21 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Timo Sarajärvi's work include Alzheimer's disease research and treatments (15 papers), Drug Transport and Resistance Mechanisms (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Timo Sarajärvi is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Drug Transport and Resistance Mechanisms (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Timo Sarajärvi collaborates with scholars based in Finland, Sweden and United States. Timo Sarajärvi's co-authors include Annakaisa Haapasalo, Mikko Hiltunen, Hilkka Soininen, Petra Mäkinen, Jayashree Viswanathan, Seppo Helisalmi, Pekka Keski‐Rahkonen, Marko Lehtonen, Jouni Ihalainen and Pasi Tavi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Timo Sarajärvi

21 papers receiving 674 citations

Peers

Countries citing papers authored by Timo Sarajärvi

Since Specialization

Citations

This map shows the geographic impact of Timo Sarajärvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Sarajärvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Sarajärvi more than expected).

Fields of papers citing papers by Timo Sarajärvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Sarajärvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Sarajärvi. The network helps show where Timo Sarajärvi may publish in the future.

Co-authorship network of co-authors of Timo Sarajärvi

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Sarajärvi. A scholar is included among the top collaborators of Timo Sarajärvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Sarajärvi. Timo Sarajärvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protein kinase C -activating isophthalate derivatives mitigate Alzheimer's disease-related cellular alterations 2018 ·Neuropharmacology ·Timo Sarajärvi, Maria Jäntti, Kaisa M. A. Paldanius, Teemu Natunen, Jing Wu, Petri Mäkinen, (unknown), Raimo K. Tuominen, Virpi Talman, Mikko Hiltunen	13
2	PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease 2017 ·Stem Cell Reports ·Minna Oksanen, Andrew J. Petersen, Nikolay Naumenko, Katja A. Puttonen, Šárka Lehtonen, (unknown), Anastasia Shakirzyanova, Stina Leskelä, Timo Sarajärvi, Matti Viitanen, Juha O. Rinne, Mikko Hiltunen, Annakaisa Haapasalo, Rashid Giniatullin, Pasi Tavi, Su‐Chun Zhang, Katja M. Kanninen, Riikka H. Hämäläinen, Jari Koıstınaho	235
3	Effects of Alzheimer’s Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients 2016 ·Journal of Alzheimer s Disease ·(unknown), Jussi Paananen, Seppo Helisalmi, Timo Sarajärvi, (unknown), Marjo Laitinen, Tuomas Rauramaa, Irina Alafuzoff, Anne M. Remes, Hilkka Soininen, Annakaisa Haapasalo, Juha E. Jääskeläinen, Ville Leinonen, Mikko Hiltunen	9
4	SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1 2016 ·Journal of Cell Science ·Kaisa M.A. Kurkinen, Mikael Marttinen, Laura Turner, Teemu Natunen, Petra Mäkinen, (unknown), Timo Sarajärvi, Sami Gabbouj, Mitja Kurki, Jussi Paananen, Anne M. Koivisto, Tuomas Rauramaa, Ville Leinonen, Heikki Tanila, Hilkka Soininen, Fiona R. Lucas, Annakaisa Haapasalo, Mikko Hiltunen	18
5	Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease 2015 ·Neurochemistry International ·Antero Salminen, Paula Jouhten, Timo Sarajärvi, Annakaisa Haapasalo, Mikko Hiltunen	39
6	Genetic Variation in δ-Opioid Receptor Associates with Increased β- and γ-Secretase Activity in the Late Stages of Alzheimer’s Disease 2015 ·Journal of Alzheimer s Disease ·Timo Sarajärvi, Mikael Marttinen, Teemu Natunen, Tarja Kauppinen, Petra Mäkinen, Seppo Helisalmi, Marjo Laitinen, Tuomas Rauramaa, Ville Leinonen, Ulla E. Petäjä‐Repo, Hilkka Soininen, Annakaisa Haapasalo, Mikko Hiltunen	13
7	P1‐082: INCREASED GAMMA‐SECRETASE ACTIVITY IN IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS PATIENTS WITH B‐AMYLOID PATHOLOGY 2014 ·Alzheimer s & Dementia ·(unknown), Timo Sarajärvi, Annakaisa Haapasalo, Lakshman Puli, Tarja Kauppinen, Petra Mäkinen, Tuomas Rauramaa, Heikki Tanila, Juha E. Jääskeläinen, Irina Alafuzoff, Hilkka Soininen, Ville Leinonen, Mikko Hiltunen	1
8	Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models 2014 ·Neurobiology of Aging ·Henna Martiskainen, Jayashree Viswanathan, Niko-Petteri Nykänen, Mitja Kurki, Seppo Helisalmi, Teemu Natunen, Timo Sarajärvi, Kaisa M.A. Kurkinen, Juha‐Pekka Pursiheimo, Tuomas Rauramaa, Irina Alafuzoff, Juha E. Jääskeläinen, Ville Leinonen, Hilkka Soininen, Annakaisa Haapasalo, Henri J. Huttunen, Mikko Hiltunen	51
9	Increased γ-Secretase Activity in Idiopathic Normal Pressure Hydrocephalus Patients with β-Amyloid Pathology 2014 ·PLoS ONE ·(unknown), Timo Sarajärvi, Annakaisa Haapasalo, Lakshman Puli, Tarja Kauppinen, Petra Mäkinen, Tuomas Rauramaa, Heikki Tanila, Juha E. Jääskeläinen, Irina Alafuzoff, Hilkka Soininen, Ville Leinonen, Mikko Hiltunen	11
10	Effects of Alzheimer's Disease-Associated Risk Loci on Cerebrospinal Fluid Biomarkers and Disease Progression: A Polygenic Risk Score Approach 2014 ·Journal of Alzheimer s Disease ·Henna Martiskainen, Seppo Helisalmi, Jayashree Viswanathan, Mitja Kurki, Anette Hall, Sanna‐Kaisa Herukka, Timo Sarajärvi, Teemu Natunen, Kaisa M.A. Kurkinen, (unknown), Petra Mäkinen, Marjo Laitinen, Anne M. Koivisto, Kari M. Mattila, Terho Lehtimäki, Anne M. Remes, Ville Leinonen, Annakaisa Haapasalo, Hilkka Soininen, Mikko Hiltunen	36
11	Effects of NR1H3 Genetic Variation on the Expression of Liver X Receptor α and the Progression of Alzheimer's Disease 2013 ·PLoS ONE ·Teemu Natunen, Henna Martiskainen, Timo Sarajärvi, Seppo Helisalmi, Juha‐Pekka Pursiheimo, Jayashree Viswanathan, Marjo Laitinen, Petra Mäkinen, Tarja Kauppinen, Tuomas Rauramaa, Ville Leinonen, Irina Alafuzoff, Annakaisa Haapasalo, Hilkka Soininen, Mikko Hiltunen	17
12	Genetic Analysis of Genes Involved in Amyloid-β Degradation and Clearance in Alzheimer's Disease 2012 ·Journal of Alzheimer s Disease ·Teemu Natunen, Seppo Helisalmi, Saila Vepsäläinen, Timo Sarajärvi, (unknown), Petra Mäkinen, Sanna‐Kaisa Herukka, Anne M. Koivisto, Annakaisa Haapasalo, Hilkka Soininen, Mikko Hiltunen	13
13	Bepridil decreasesAβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats 2012 ·Journal of Cellular and Molecular Medicine ·Timo Sarajärvi, (unknown), Petra Mäkinen, Sirpa Peräniemi, Hilkka Soininen, Annakaisa Haapasalo, Jukka Jolkkonen, Mikko Hiltunen	18
14	Effects of memantine and donepezil on cortical and hippocampal acetylcholine levels and object recognition memory in rats 2011 ·Neuropharmacology ·Jouni Ihalainen, Timo Sarajärvi, (unknown), Susanna Kemppainen, Pekka Keski‐Rahkonen, Marko Lehtonen, Pradeep Banerjee, Kazue Semba, Heikki Tanila	34
15	Cysteine 27 Variant of the δ-Opioid Receptor Affects Amyloid Precursor Protein Processing through Altered Endocytic Trafficking 2011 ·Molecular and Cellular Biology ·Timo Sarajärvi, Jussi Tuusa, Annakaisa Haapasalo, (unknown), Raija Sormunen, Seppo Helisalmi, Johannes T. Roehr, Antonio Parrado, Petra Mäkinen, Lars Bertram, Hilkka Soininen, Rudolph E. Tanzi, Ulla E. Petäjä‐Repo, Mikko Hiltunen	29
16	A novel delayed non-match to sample object recognition task that allows simultaneous in vivo microdialysis 2010 ·Journal of Neuroscience Methods ·Jouni Ihalainen, Timo Sarajärvi, Susanna Kemppainen, Pekka Keski‐Rahkonen, Marko Lehtonen, Heikki Tanila	12
17	An Association Study of 21 Potential Alzheimer's Disease Risk Genes in a Finnish Population 2010 ·Journal of Alzheimer s Disease ·Timo Sarajärvi, Seppo Helisalmi, (unknown), Petra Mäkinen, Anne M. Koivisto, Sanna‐Kaisa Herukka, Annakaisa Haapasalo, Hilkka Soininen, Mikko Hiltunen	13
18	Down-regulation of Seladin-1 Increases BACE1 Levels and Activity through Enhanced GGA3 Depletion during Apoptosis 2009 ·Journal of Biological Chemistry ·Timo Sarajärvi, Annakaisa Haapasalo, Jayashree Viswanathan, Petra Mäkinen, Marjo Laitinen, Hilkka Soininen, Mikko Hiltunen	55
19	CALHM1 P86L polymorphism does not alter amyloid-β or tau in cerebrospinal fluid 2009 ·Neuroscience Letters ·Vilmantas Giedraitis, Anna Glaser, Timo Sarajärvi, RoseMarie Brundin, (unknown), Brit‐Maren M. Schjeide, Rudolph E. Tanzi, Seppo Helisalmi, Tuula Pirttilä, Lena Kilander, Lars Lannfelt, Hilkka Soininen, Lars Bertram, Martin Ingelsson, Mikko Hiltunen	9
20	Quantitative determination of acetylcholine in microdialysis samples using liquid chromatography/atmospheric pressure spray ionization mass spectrometry 2007 ·Rapid Communications in Mass Spectrometry ·Pekka Keski‐Rahkonen, Marko Lehtonen, Jouni Ihalainen, Timo Sarajärvi, Seppo Auriola	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact